Tag - medicine-4

 
Menu
Search
 
July 28, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

MEDICINE 4

Japan Times
BUSINESS / Companies
Nov 30, 2022
Japanese biotech firm uses tiny worms in test for pancreatic cancer
The creatures, a species of nematodes known scientifically as C. elegans, have olfactory senses much more powerful than dogs, the firm says, and they follow their nose toward cancer cells.
Japan Times
BUSINESS
Nov 30, 2022
Eisai Alzheimer’s drug sparks debate over benefits as risks like brain bleeding emerge
The key issue is whether the modest slowing of the disease is meaningful to individual patients and their families, especially in light of the potential side effects.
Japan Times
WORLD / Science & Health
Nov 29, 2022
Scientists revive 48,500-year-old ‘zombie virus’ buried in ice
Scientists have long warned that the thawing of permafrost due to atmospheric warming will worsen climate change. But its effect on dormant pathogens is less well understood.
Japan Times
BUSINESS / Markets
Nov 29, 2022
Eisai and Biogen plunge after report of second death in Alzheimer’s trial
The case involved a 65-year-old woman who died of a massive brain hemorrhage after suffering a stroke and a type of brain swelling and bleeding in an Eisai trial, a report said.
Japan Times
JAPAN
Nov 25, 2022
Human rights violations confirmed at leprosy sanatorium
According to the report, 1,674 residents died in the facility between 1938 and 1998, and autopsies were performed on 1,184 of them, about 70% of the total.
Japan Times
WORLD / Science & Health
Nov 25, 2022
Researchers test mRNA technology for universal flu vaccine
A universal vaccine would not mean an end to flu seasons, but would replace the guess work that goes into developing annual shots months ahead of flu season each year.
Japan Times
JAPAN / Science & Health
Nov 24, 2022
Shionogi applies for COVID-19 vaccine approval, would be first Japan-made
The recombinant protein-based preventive vaccine is the same type as a COVID-19 vaccine developed by Novavax and differs from messenger RNA vaccines developed by Pfizer or Moderna.
Japan Times
JAPAN
Nov 22, 2022
TV dramas leading more young people into forensics
Senior forensic doctors are welcoming the movement as a 'bright sign' for the future of the practice, which has often been marginalized.
Japan Times
COMMENTARY / World
Nov 21, 2022
Pfizer’s RSV vaccine succeeds where others failed
Early data bodes well for Pfizer's RSV shot, which would be given during pregnancy to protect infants in the early months of life.
Japan Times
COMMENTARY / World
Nov 18, 2022
Why China won't cooperate on finding the origins of COVID-19
For Beijing, winning its u2018people's war' against the coronavirus by controlling the propaganda narrative is more important than learning the truth about the pandemic.
Japan Times
COMMENTARY / World
Nov 16, 2022
New weight-loss drugs work, but who's paying?
Novo Nordisk and Eli Lilly say they can treat obesity with a weekly injection. But insurers aren't yet on board.
Japan Times
COMMENTARY / World
Nov 15, 2022
Why China won’t end its 'COVID zero' policy
Chinese President Xi Jinping early on took ownership of the battle against the coronavirus — now his political legitimacy rests on the outcome.
Japan Times
JAPAN / FOCUS
Nov 14, 2022
Crowdfunding helping plug gap in government funding for academic research
The fundraising mechanism has also come into wider use in the nation's medical community, with some cases of research gathering pace after collecting large amounts of financial support.
Japan Times
COMMENTARY / World
Nov 14, 2022
If you’ve had COVID-19, watch out for stroke symptoms
Several studies now show an elevated risk of serious blood vessel inflammation during and after an infection.
Japan Times
WORLD / Science & Health
Nov 13, 2022
G20 unveils global pandemic fund to avoid repeat of COVID-19
The World Bank will manage the G20 fund to address future COVID-19 pandemics, drawing commitments from more than 20 counties, the Bill & Melinda Gates Foundation and others.
Japan Times
BUSINESS
Nov 12, 2022
Takeda to seek Japan approval for dengue vaccine
The firm's CEO said Takeda will prioritize regulatory approval in endemic countries, and that it will later seek approval in Japan to make it available for travelers.
Japan Times
ASIA PACIFIC
Nov 8, 2022
As pandemic eases, more Filipino nurses set to seek work abroad
Filipino nurses fluent in English are in high demand overseas. As of the end of 2021, over 310,000 of more than 910,000 registered nurses in the Philippines were working abroad.
Japan Times
WORLD / Science & Health
Nov 7, 2022
Pfizer’s Paxlovid anti-viral seen to lower long-COVID risk in study
Taking the oral medication within five days of testing positive for a SARS-CoV-2 infection was linked to a 26% lower risk of lingering post-viral complications, researchers found.
Japan Times
COMMENTARY / World
Oct 31, 2022
Better cancer screenings are coming. Can we afford them?
Regular cancer tests are an important tool for catching tumors early, but the financial incentives of hospitals and patients aren't always aligned.
Japan Times
COMMENTARY / World
Oct 30, 2022
Just one case of polio is a global threat
The polio outbreak in New York demonstrates the importance of sustained eradication efforts.
Japan's population continues to fall even as foreign resident count rises
The number of residents in Tokyo as of Jan. 1 rose by 0.03% from a year before, data shows, marking a year-on-year increase for the first time in three years, while the country's other 46 prefectures saw their populations continue to decline.
Ahead of the Olympics, Japan is still talking about the gymnast who won't be there
Japan's Shoko Miyata withdrew from the gymnastics team herself over her drinking and smoking, although it had already appeared as though the association was prepared to send her home from the team’s training camp in Monaco.
Yen melt-up nudges Japanese stocks into correction territory
Japanese stocks are down 10% from their July peak as the yen strengthens.
‘Crazy’ yen rally is at risk of shattering as soon as Wednesday
Some investors are warning that a yen rally is fragile, as was on show this week when the yen rapidly retraced an advance after Thursday’s stronger-than-expected U.S. economic growth figures.
Japan's average life expectancy rises for first time in three years
A decline in COVID-19-caused deaths likely helped boost the average life expectancy for Japanese men and women to rise for the first time in three years in 2023.
The Japanese Olympians looking to shine in Paris
Rim Nakamura, who is attempting to win Japan's first Olympic gold medal in cycling, will be one of the top Japanese athletes to watch at the Paris Games.
Japan’s minimum wage set for record ¥50 hike in major boost
Demonstrators rally to demand a big hike in minimum wages in Tokyo last week.
Japan loses top spot on strongest passport list to Singapore
Japan had the strongest passport for six years running from 2018, before being dethroned by Singapore on the 2024 list.
Why Japan's mysterious stash of classified funds escapes scrutiny
Prime Minister Fumio Kishida and Chief Cabinet Secretary Yoshimasa Hayashi (right) during a meeting in Tokyo on Tuesday.
Japan eyes gold — and the future — as Olympic men's soccer campaign begins
Japan midfielder Yu Hirakawa controls the ball during a match against the United States in Kansas City, Kansas, on June 11.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Traditional folk rituals like Mizudome-no-mai (dance to stop the rain) provide a sense of agency to a population that feels largely powerless in the face of the climate crisis.
As climate extremes intensify, Japan embraces ancient weather rituals
By Alex K.T. Martin

SUSTAINABLE JAPAN

JNTO promotes sustainable tourism initiatives
JNTO promotes sustainable tourism initiatives

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER